Healthcare provider profile · identity verified

Rashid Alsabeh, M.D.

Hospitalist · GROSSE POINTE PARK, MI · NPI 1093788150

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	199
Amlodipine Besylate	Amlodipine Besylate	435	128
Lisinopril	Lisinopril	372	98
Losartan Potassium	Losartan Potassium	361	118
Levothyroxine Sodium	Levothyroxine Sodium	340	96
Tamsulosin Hcl	Tamsulosin Hcl	338	103
Metformin Hcl	Metformin Hcl	334	93
Rosuvastatin Calcium	Rosuvastatin Calcium	279	92
Simvastatin	Simvastatin	263	65
Metoprolol Succinate	Metoprolol Succinate	245	78
Omeprazole	Omeprazole	239	79
Eliquis	Apixaban	226	70
Metformin Hcl Er	Metformin Hcl	225	64
Gabapentin	Gabapentin	216	58
Pantoprazole Sodium	Pantoprazole Sodium	197	61
Jardiance	Empagliflozin	176	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	172	22
Metoprolol Tartrate	Metoprolol Tartrate	156	44
Allopurinol	Allopurinol	149	48
Albuterol Sulfate Hfa	Albuterol Sulfate	145	44
Hydrochlorothiazide	Hydrochlorothiazide	144	55
Furosemide	Furosemide	136	54
Spironolactone	Spironolactone	123	35
Atenolol	Atenolol	119	37
Famotidine	Famotidine	117	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	30
Glimepiride	Glimepiride	106	29
Alprazolam	Alprazolam	105	25
Pravastatin Sodium	Pravastatin Sodium	104	33
Carvedilol	Carvedilol	100	33
Finasteride	Finasteride	97	29
Fluticasone Propionate	Fluticasone Propionate	96	38
Sertraline Hcl	Sertraline Hcl	94	22
Ozempic	Semaglutide	92	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	91	24
Methocarbamol	Methocarbamol	85	39
Tramadol Hcl	Tramadol Hcl	85	17
Clopidogrel	Clopidogrel Bisulfate	81	28
Potassium Chloride	Potassium Chloride	80	28
Escitalopram Oxalate	Escitalopram Oxalate	78	20
Ezetimibe	Ezetimibe	78	27
Prednisone	Prednisone	74	45
Donepezil Hcl	Donepezil Hcl	73	23
Alendronate Sodium	Alendronate Sodium	71	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	19
Duloxetine Hcl	Duloxetine Hcl	65	20
Nifedipine Er	Nifedipine	65	19
Clonazepam	Clonazepam	64	suppressed
Hydralazine Hcl	Hydralazine Hcl	64	16
Warfarin Sodium	Warfarin Sodium	63	17
Trazodone Hcl	Trazodone Hcl	62	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Mounjaro	Tirzepatide	55	14
Zolpidem Tartrate	Zolpidem Tartrate	55	14
Pregabalin	Pregabalin	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	17
Ventolin Hfa	Albuterol Sulfate	52	16
Januvia	Sitagliptin Phosphate	51	15
Citalopram Hbr	Citalopram Hydrobromide	49	15
Diazepam	Diazepam	48	18
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	13
Pioglitazone Hcl	Pioglitazone Hcl	46	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	45	suppressed
Montelukast Sodium	Montelukast Sodium	45	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	13
Baclofen	Baclofen	42	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	22
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	41	41
Lorazepam	Lorazepam	40	11
Celecoxib	Celecoxib	35	12
Bupropion Hcl Sr	Bupropion Hcl	34	12
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	22
Vitamin D2	Ergocalciferol (Vitamin D2)	34	suppressed
Meloxicam	Meloxicam	33	21
Mirtazapine	Mirtazapine	33	12
Bumetanide	Bumetanide	32	13
Trulicity	Dulaglutide	32	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	31	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	31	24
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Myrbetriq	Mirabegron	29	suppressed
Ibuprofen	Ibuprofen	28	11
Nystatin	Nystatin	28	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	14
Cephalexin	Cephalexin	26	24
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Glipizide	Glipizide	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Tiotropium Bromide	Tiotropium Bromide	25	11
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Ketoconazole	Ketoconazole	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Nitroglycerin	Nitroglycerin	21	13
Valacyclovir	Valacyclovir Hcl	21	suppressed
Lidocaine	Lidocaine	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Amoxicillin	Amoxicillin	18	14
Farxiga	Dapagliflozin Propanediol	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Benzonatate	Benzonatate	17	11
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Valsartan	Valsartan	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Metolazone	Metolazone	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Naproxen	Naproxen	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Memantine Hcl	Memantine Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Azithromycin	Azithromycin	12	12
Chlorthalidone	Chlorthalidone	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Mirabegron Er	Mirabegron	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error